Successful Treatment of Recurrent Pericarditis With Rilonacept in Acute Promyelocytic Leukemia

Mustafa Atar1, Muhammad Majid1,2, Zachary Yaker1

  • 1Center for Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

JACC. Case Reports
|December 14, 2023
PubMed
Summary

Recurrent pericarditis in acute promyelocytic leukemia patients can be challenging. Interleukin-1 inhibitor rilonacept offers a successful treatment option for refractory cases.